Overview
- 42 inspections across 42 sites are on record.
- 62 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-04.
At a glance
Inspections
42
Sites
42
Observations
62
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bachem Americas, Inc. | 4 May 2026 | Human Drugs | On file |
| PETNET Solutions Inc | 19 Mar 2026 | Human Drugs | On file |
| Cardinal Health 414, LLC | 16 Mar 2026 | Human Drugs | |
| Pharmalogic Salt Lake City, LLC | 24 Feb 2026 | Human Drugs | On file |
| J.M. Huber Micropowders, Inc. | 11 Feb 2026 | Human Drugs | On file |
Sites inspected
Bachem Americas, Inc.Torrance, United States1 insp.
PETNET Solutions IncBirmingham, United States1 insp.
Cardinal Health 414, LLCBirmingham, United States1 insp.
Pharmalogic Salt Lake City, LLCSalt Lake City, United States1 insp.
J.M. Huber Micropowders, Inc.La Mirada, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Youkeun Kim6 shared
Andrew Le4 shared
Khoa Nathan V Tran4 shared
Rowena S Nguyen3 shared
Karen A Briggs3 shared
Crystal Monroy3 shared
Matthew R Clabeaux2 shared
Joey V Quitania2 shared
Homero W Aguilar2 shared
Walden H Lee2 shared
Full investigator report
Get the verbatim findings behind Lillian S Wu's 62 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site